Home > Boards > US OTC > Medical - Drugs >

Provectus Biopharmaceuticals Inc. (PVCT)

PVCT RSS Feed
Add PVCT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/9/2019 9:26:19 AM - Followers: 190 - Board type: Free - Posts Today: 0







Business Description

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer and liver cancer. Provectus investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for psoriasis. In addition, Provectus has begun a Phase 3 trial as a therapy for metastatic melanoma. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com.

The red synthetic dye Rose Bengal is shown in a bottle at Provectus Pharmaceuticals, Inc.


 


CURRENT PVCT PIPELINE (as of May 23, 2017)

--------------------------------------------------------------

Charts and Technical:

PVCT 6 months chart:
http://stockcharts.com/h-sc/ui?s=PVCT&p=D&yr=0&mn=6&dy=0&id=p03754661229

Technical analysis:
http://www.stockta.com/cgi-bin/analysis.pl?symb=PVCT&num1=7&cobrand=&mode=stock

PVCT News and Analysis:

PVCT News Blog with the latest news and analysis:

http://provectuspharmaceuticalsinc.blogspot.ca/p/news.html 

CONNECTING THE DOTS - CURRENT NEWS PAGE
http://provectuspharmaceuticalsinc.blogspot.ca/p/current-news_22.html

CONNECTING THE DOTS - BLOG PAGE

http://provectuspharmaceuticalsinc.blogspot.ca/


PVCT News at OTC 
http://www.otcmarkets.com/stock/PVCT/news

CLINICAL TRIALS Updates and Info:

FOR PV-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PV-10&Search=Search

FOR PH-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PH-10&Search=Search

PVCT insiders transactions:
http://www.secform4.com/insider/showhistory.php?symbol=pvct



For Clinical Trials and Compassionate Use Programs, Investor Information including SEC filing and Corporate Presentations, Press and Media Releases, and Contact information:
http://www.pvct.com/index.html

PVCT on YouTube...
http://www.youtube.com/watch?v=nuYpvcnAq4c

------------------------------------------------------------

Contact Info:

Telephone: (866) 594-5999
info@pvct.com
scott@pvct.com

Mailing Address:

Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

--------------------------------------------------------------

PVCT Share Structure
Market Value:  $18,517,732 a/o May 04, 2017
Authorized Shares:  1,000,000,000  a/o Apr 30, 2017
Outstanding Shares:  370,354,643  a/o Apr 30, 2017
-Restricted:  N/A
-Unrestricted:  N/A
Held at DTC: N/A
Float:  75,807,312  a/o Jun 30, 2016
Par Value:  0.001
Transfer Agent  Broadridge Financial Solutions, Inc.
Shareholders of Record:  972 a/o Mar 31, 2017
Short Selling Data
Short Interest 167,323 (69.16%)
Apr 13, 2017
Significant Failures to Deliver No





Insider Shares:
http://www.nasdaq.com/symbol/pvct/insider-trades

Institutional Ownership:
http://www.nasdaq.com/symbol/pvct/institutional-holdings

--------------------------------------------------------------

10Q Filed May 10, 2017:


https://ih.advfn.com/p.php?pid=nmona&article=74554789

8K Filed June 1, 2017; Board elected, no share increase

http://ih.advfn.com/p.php?pid=nmona&article=74843932&symbol=PVCT

8K filed August 1, 2017; Provectus Biopharmaceuticals, Inc. is entitled to receive total damages of $6,027,652

http://ih.advfn.com/p.php?pid=nmona&article=75359078

8K filed October 18, 2917; Provectus announces results from the Company’s ongoing Phase 1b/2 study of IL PV-10 in combination with KEYTRUDA® (pembrolizumab)

https://www.sec.gov/Archives/edgar/data/315545/000149315217011744/ex99-1.htm
PVCT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#9668   NEWS -- Provectus Appoints Bruce Horowitz as Chief Paulness 05/09/19 09:26:18 AM
#9667   270 shares to drop this stock 75%? kentstate12 05/03/19 09:57:22 AM
#9666   wow, 270 shares sold to drop this stock kentstate12 04/30/19 09:50:12 AM
#9665   NEWS -- Provectus Biopharmaceuticals Announces Acceptances of PV-10 Paulness 04/17/19 04:33:03 PM
#9664   NEWS frosen 04/17/19 04:13:24 PM
#9663   This actually saves the company money. Leave_the_gun 03/26/19 01:47:41 PM
#9662   It all sounds good, but how much money kentstate12 03/26/19 01:16:02 PM
#9661   PV-10 Trial Updated Leave_the_gun 03/26/19 01:13:40 PM
#9660   NEWS -- Provectus Appoints Heather Raines, CPA as Paulness 03/25/19 09:38:36 AM
#9659   Provectus appoints Heather Raines as Chief Financial Officer kentstate12 03/25/19 09:21:50 AM
#9658   NEWS -- Provectus Provides Update on Metastatic Uveal Paulness 03/21/19 09:17:05 AM
#9657   Massive bid support here now very unusual, frosen 03/13/19 02:56:45 PM
#9656   news and we hit .075 ish - .08 easy. bleach_ 03/05/19 01:53:28 PM
#9655   What an idiot, shorts are getting desperate frosen 03/05/19 11:48:39 AM
#9654   Except for the PR they just put out Leave_the_gun 03/05/19 10:57:09 AM
#9653   Make a phone call. If you reach jdlamont 03/05/19 10:46:40 AM
#9652   This stock looks ready to pop soon. Big frosen 02/27/19 12:51:22 PM
#9651   Level 2 is very thin on the ask frosen 02/26/19 03:55:03 PM
#9650   Thanks for clarification frosen 02/23/19 10:28:14 PM
#9649   Alan Ross is a complete fraud. He's lying Leave_the_gun 02/21/19 10:16:41 PM
#9648   Where is this Alan Ross spreading this info? kentstate12 02/21/19 03:18:45 PM
#9647   PRH Group does NOT get $200M off the RutgersAnthony 02/20/19 11:21:05 PM
#9646   Higher highs and higher lows today, .057-.0648 looking frosen 02/20/19 04:18:29 PM
#9645   NEWS -- Article on anti-tumor activity of PV-10 Paulness 02/19/19 08:56:16 AM
#9644   https://www.mossreports.com/keytruda-immunotherapy-for-cancer-better-than-chemot frosen 02/14/19 09:09:20 AM
#9643   Here's why yesterday's news is significant: http://www.pharmexec.com/are-right frosen 02/13/19 12:32:00 PM
#9642   Level 2 very thin to .0725 frosen 02/13/19 09:51:32 AM
#9641   How does this stock get off blue sky list? kentstate12 02/12/19 01:08:15 PM
#9640   NEWS -- PROVECTUS ANNOUNCES GRANT OF ORPHAN DRUG Paulness 02/12/19 08:25:16 AM
#9639   New Orphan Drug Designation for PVCT today 02/11/2019 estocks 02/11/19 10:50:52 PM
#9638   New Orphan Drug Designation for PVCT today 02/11/2019 estocks 02/11/19 10:49:53 PM
#9637   New Orphan Drug Designation for PVCT today 02/11/2019 estocks 02/11/19 10:49:05 PM
#9636   Hope springs eternal, but having someone know something kentstate12 02/11/19 12:52:34 PM
#9635   What's going on here? Nice volume coming in. frosen 02/11/19 12:17:36 PM
#9634   Watch them lining up on the bid at frosen 01/25/19 02:52:58 PM
#9633   Short squeeze!!!!. Northbound to Greenland frosen 01/25/19 09:49:10 AM
#9632   Green again frosen 01/10/19 11:30:31 AM
#9631   Stop smoking the crack gblxwhale 01/09/19 09:03:19 PM
#9630   Can this stock do a LOXO move? Wow frosen 01/09/19 11:04:25 AM
#9629   http://www.evaluate.com/vantage/articles/news/snippets/another-must-have-oncolyt frosen 01/09/19 10:58:30 AM
#9628   Yes, green again frosen 01/08/19 11:25:30 AM
#9627   Haha yeah right gblxwhale 01/07/19 02:25:47 PM
#9626   The engine is revving up!! frosen 01/07/19 02:09:06 PM
#9625   Nice bid support, this is going green frosen 12/27/18 12:43:58 PM
#9624   13 years in this turd!!!!!!!! Fck you Dees gblxwhale 12/24/18 11:04:44 PM
#9623   Picked up some more shares, averaging down. frosen 12/24/18 01:05:05 PM
#9622   The PhII PH-10 trial has just been completed https://clinicaltrials.gov/c longfellow95 12/10/18 01:58:52 PM
#9621   NEWS -- PROVECTUS BIOPHARMACEUTICALS PROVIDES UPDATE ON MELANOMA Paulness 12/06/18 09:51:18 AM
#9617   Videos of/about Ed P Accepting Haslam Award RutgersAnthony 11/18/18 04:55:03 AM
#9616   News Story Search Company 11/14/2018 07:00:00 AM PROVECTUS BIOPHARMACEUTICALS P Swanraninto 11/14/18 07:46:02 AM
PostSubject